Clinical Trial Update: Special Drug Use Surveillance of Irribow in Female Patients

View source ↗

Summary

Astellas reports the completion of a post-market surveillance study evaluating Irribow in female patients with Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Irribow

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Diarrhea-predominant Irritable Bowel Syndrome | Status: COMPLETED